| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.0066 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0045 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |